Kennedy's HHS Nomination Sparks Mixed Reactions in Medtech Sector

Robert F. Kennedy Jr.'s nomination to lead the US Department of Health and Human Services has generated both cautious optimism and concerns in the medtech sector, with concerns including a less science-based regulatory environment and potential user fee cuts.

Robert F. Kennedy Jr. holds a campaign rally in January 2024
(Bryan Regan/Shutterstock)

More from Medtech Insight

More from Policy & Regulation